Abstract:Introduction Patients with polycystic kidney disease (PKD) may develop various forms of cardiomyopathies, which can progress to heart failure (HF) and subsequently result in cardio-renal syndrome (CRS). Bicaudal C homolog 1 (Bicc1) is an evolutionarily conserved RNA-binding protein that has crucial roles in the formation and development of numerous organs, including the heart and kidneys. It is also an essential genetic determinant in autosomal dominant polycystic kidney disease (ADPKD). Prior research has highlighted the significant role of Bicc1 in heart and kidney development as well as in PKD formation. However, the involvement of Bicc1 in ADPKD-associated HF has not yet been explored. Hypothesis We hypothesize that Bicc1 levels are elevated in heart failure and CRS. Methods To investigate the role of Bicc1 in HF, we analyzed its expression level from RNA-seq data generated from the Myocardial Applied Genomics Network human RNA-seq dataset from failing and non-failing explanted hearts. We also assessed the circulating BICC1 levels using an enzyme-linked immunosorbent assay in patients with various CRS conditions and heart failure as well as in healthy controls. Results In the RNA-seq dataset, Bicc1 RNA level (normalized read counts) was increased by 1.4-fold in the hearts of patients with dilated cardiomyopathy (1100.1±43.7, p<0.001) and by 1.5-fold in hypertrophic cardiomyopathy (1155.2±122.1, p<0.001) compared to healthy donors (771.1±25.8). In our study cohort (mean age 64±12 years, 53% male), we compared the median BICC1 plasma levels in healthy controls (n=34) with ADHF patients (n=37; 0.06 vs 1.067 ng/ml, p<0.001 by Mann-Whitney test). Of note, creatinine levels were 0.91±0.03 mg/dL in controls and 2.13±0.09 mg/dL in ADHF patients. Conclusions Bicc1 is upregulated in the failing heart and circulating Bicc1 levels are elevated patients with ADHF and track with rising creatinine levels.

BICC1 Interacts with PKD1 and PKD2 to Drive Cystogenesis in ADPKD

The Role of the Co-Chaperone DNAJB11 in Polycystic Kidney Disease: Molecular Mechanisms and Cellular Origin of Cyst Formation

Cilia to basement membrane signalling is a biomechanical driver of autosomal dominant polycystic kidney disease

Loss of Bicc1 impairs tubulomorphogenesis of cultured IMCD cells by disrupting E-cadherin-based cell-cell adhesion

Protein Phosphatase 1α Interacts with a Novel Ciliary Targeting Sequence of Polycystin‐1 and Regulates Polycystin‐1 Trafficking

Polycystic Kidney Disease: Novel Insights into Polycystin Function.

Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis

Cyclin-Dependent Kinase 1 Activity is a Driver of Cyst Growth in Polycystic Kidney Disease.

Bicc1: A Potential Biomarker For Heart Failure And Cardio-Renal Syndrome

Identification of ADPKD-Related Genes and Pathways in Cells Overexpressing PKD2

Single-Cell and CellChat Resolution Identifies Collecting Duct Cell Subsets and Their Communications with Adjacent Cells in PKD Kidneys

Conditional Mutation of Pkd2 Causes Cystogenesis and Upregulates Beta-Catenin.

In vivo Polycystin-1 interactome using a novel Pkd1 knock-in mouse model

A Rare Deep Intronic Mutation of PKHD1 Gene, C.8798-459 C > A, Causes Autosomal Recessive Polycystic Kidney Disease by Pseudoexon Activation

ADPKD-Causing Missense Variants in Polycystin-1 Disrupt Cell Surface Localization or Polycystin Channel Function

Two Novel Mutations Affecting the Same Splice Site of PKD1 Correlate with Different Phenotypes in ADPKD.

Sperm morphological abnormalities in autosomal dominant polycystic kidney disease are associated with the Hippo signaling pathway via PC1

Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease

Polycystin-2 Mediated Calcium Signalling in the Dictyostelium Model for Autosomal Dominant Polycystic Kidney Disease

PKD1 Deficiency Induces Bronchiectasis in a Porcine ADPKD Model

Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.